The Federal Trade Commission has signaled the withdrawal of two antitrust policy statements related to enforcement in healthcare markets: Statements of Antitrust Enforcement Policy in Health Care, published in August 1996, and
Dr. Amar Desai, who had previously spent years in various leadership roles at Optum Health, has returned to the company and will take over the role of CEO, according to a message Desai posted on LinkedIn.
Steven Ramirez, CISO at Renown Health, and Steve Cagle, CEO at Clearwater, said their organizations have teamed up to ensure better security from a HIPAA and threat actor perspective.
Elevance Health posted a strong second quarter, achieving about $1.9 billion in revenue, good for 13.2% growth over the previous year’s $1.6 billion haul, according to the company’s latest earnings report. Revenues also grew 12.7%, hitting $43.7 billion, an increase from the $38.6 billion in revenue posted in Q2 2022.
The Federal Trade Commission is seeking to block IQVIA, the world’s largest healthcare data provider, from acquiring Propel Media (PMI), alleging in an administrative complaint that the proposed acquisition would give IQVIA a market-leading position in programmatic advertising for healthcare products – namely prescription drugs – to doctors and other healthc
Two Florida men pleaded guilty last week for their roles in a scheme to defraud Medicare by submitting over $67 million in false claims for genetic testing and durable medical equipment that patients did not need and that the defendants procured with kickbacks. The pleas came after four days of trial in the Southern District […]
On Tuesday, U.S. Department of Health and Human Services Secretary Xavier Becerra, Director of the Domestic Policy Council of the United States Neera Tanden, and Administrator of the Centers for Medicare and Medicaid Services Chiquita Brooks-LaSure held a roundtable at the White House with pharmacy chain and association leaders.
Shine Technology is looking to develop partnerships with American companies, says David Chen, director of business development for the company, a medical device supplier in Beijing.
The second quarter saw an increase in merger and acquisition-related transactions – 20 overall, as compared to 15 transactions in Q1. This, according to a new Kaufman Hall analysis, brought Q2 in line with pre-pandemic levels.
Healthcare and doctors’ groups are unhappy with the Centers for Medicare and Medicaid Services’ proposed cuts to physician payments in its annual fee schedule, and are calling on Congress to intervene, hoping to stave off a 3.34% cut to the fee schedule’s conversion factor – used to calculate Medicare payments to doctors.